These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14215189)

  • 21. Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.
    Benenson AS; Saad A; Mosley WH; Ahmed A
    Bull World Health Organ; 1968; 38(2):287-95. PubMed ID: 5302304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
    Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
    Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of revaccination in persons inoculated primarily with whole-cell and toxoid cholera vaccines].
    Kiseleva IE; Domaradskiĭ IV; Erokhin EP; Kirdeev VK; Kiseleva VI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):64-7. PubMed ID: 4409388
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin.
    Cruce DD; Wachsmuth IK; Feeley JC
    Diagn Immunol; 1983; 1(2):87-9. PubMed ID: 6680095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
    Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
    PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SEROLOGICAL STUDIES ON CHOLERA. I. ANTIBODY LEVELS OBSERVED IN VACCINATED AND CONVALESCENT PERSONS.
    BERAN GW
    Am J Trop Med Hyg; 1964 Sep; 13():698-707. PubMed ID: 14205890
    [No Abstract]   [Full Text] [Related]  

  • 28. Antigenic analysis of vibrio culture filtrate and vaccine El Tor vibrio.
    Sanyal SC; Narayanaswami A; Mukerjee S
    J Hyg (Lond); 1969 Sep; 67(3):539-44. PubMed ID: 4980363
    [No Abstract]   [Full Text] [Related]  

  • 29. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.
    Neoh SH; Rowley D
    J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023
    [No Abstract]   [Full Text] [Related]  

  • 30. Active and passive immunization in the adult rabbit ileal loop model as an assay for production of antitoxin immunity by cholera vaccines.
    Mosley WH; Ahmed A
    J Bacteriol; 1969 Oct; 100(1):547-9. PubMed ID: 5344118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some observations on the cholera (E1 Tor) epidemic in 1961-62.
    FELSENFELD O
    Bull World Health Organ; 1963; 28(3):289-96. PubMed ID: 13962884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the Seemueller phenomenon. III. Serological demonstration of intravital fixation of hemagglutinins and hemolysins by diphtheria toxin].
    SCHIFF W
    Z Immun exp ther; 1961 Oct; 122():95-113. PubMed ID: 14498364
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins.
    Olivier V; Salzman NH; Satchell KJ
    Infect Immun; 2007 Oct; 75(10):5043-51. PubMed ID: 17698571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
    Lahiri A; Agarwal RK; Sanyal SC
    J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological studies in cholera infection in Calcutta (1966-67).
    Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W
    Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991
    [No Abstract]   [Full Text] [Related]  

  • 36. [Avidity of specific antibodies in the sera of cholera patients and vibrio carriers].
    Bunin KV; Firsanov VI; Parfenova NN; Kravtsov EG; Nechaeva IP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):70-4. PubMed ID: 1015080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model.
    Saha S; Sanyal SC
    Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence patterns of Vibrio cholerae non-O1 strains isolated from hospitalised patients with acute diarrhoea in Calcutta, India.
    Ramamurthy T; Bag PK; Pal A; Bhattacharya SK; Bhattacharya MK; Shimada T; Takeda T; Karasawa T; Kurazono H; Takeda Y
    J Med Microbiol; 1993 Oct; 39(4):310-7. PubMed ID: 8411093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VIRULENCE OF EL TOR VIBRIOS FOR CHICK EMBRYOS.
    FINKELSTEIN RA
    Nature; 1964 May; 202():609-10. PubMed ID: 14195078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.